Re: Q1- March 31, 2022 on SEDAR
in response to
by
posted on
May 14, 2022 08:22PM
Just wondering if a white knight might come in to help RVX, Oristar has new biotech fund and I am wondering if they would invest for the BETONMACE2 trial, or Hepalink coming to help , then again I wonder if Zenith Epigenetics might be sold off which could help RvX finances , wishful thinking but you never know , RVX has come back from the dead after the betonmace trial fail.